메뉴 건너뛰기




Volumn 56, Issue 9, 2007, Pages 2919-2928

Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BIOLOGICAL MARKER; COLLAGEN TYPE 2; ETANERCEPT; INFLIXIMAB; PROCOLLAGEN; PROCOLLAGEN TYPE 2; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

EID: 34848906320     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22843     Document Type: Article
Times cited : (41)

References (43)
  • 1
    • 0025304539 scopus 로고
    • Rheumatoid arthritis. Pathophysiology and implications for therapy
    • Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
    • (1990) N Engl J Med , vol.322 , pp. 1277-1289
    • Harris Jr., E.D.1
  • 2
    • 0032981611 scopus 로고    scopus 로고
    • Van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000 Jan;27:261-3]. J Rheumatol 1999;26:743-5.
    • Van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000 Jan;27:261-3]. J Rheumatol 1999;26:743-5.
  • 3
    • 0033501902 scopus 로고    scopus 로고
    • Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time
    • Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
    • (1999) Arthritis Rheum , vol.42 , pp. 1854-1860
    • Drossaers-Bakker, K.W.1    de Buck, M.2    van Zeben, D.3    Zwinderman, A.H.4    Breedveld, F.C.5    Hazes, J.M.6
  • 4
    • 0027238592 scopus 로고
    • The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
    • Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
    • (1993) Arthritis Rheum , vol.36 , pp. 729-740
    • Felson, D.T.1    Anderson, J.J.2    Boers, M.3    Bombardier, C.4    Chernoff, M.5    Fried, B.6
  • 5
    • 0031451998 scopus 로고    scopus 로고
    • Combination therapy in early rheumatoid arthritis: The COBRA study
    • In Dutch
    • Boers M, Verhoeven AC, van der Linden S. Combination therapy in early rheumatoid arthritis: the COBRA study. Ned Tijdschr Geneeskd 1997;141:2428-32. In Dutch.
    • (1997) Ned Tijdschr Geneeskd , vol.141 , pp. 2428-2432
    • Boers, M.1    Verhoeven, A.C.2    van der Linden, S.3
  • 6
    • 17244364098 scopus 로고    scopus 로고
    • Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study
    • Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study. Arthritis Rheum 2005;52:1020-30.
    • (2005) Arthritis Rheum , vol.52 , pp. 1020-1030
    • Smolen, J.S.1    Han, C.2    Bala, M.3    Maini, R.N.4    Kalden, J.R.5    van der Heijde, D.6
  • 7
    • 0031715621 scopus 로고    scopus 로고
    • Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
    • Van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
    • (1998) Arthritis Rheum , vol.41 , pp. 1845-1850
    • Van Gestel, A.M.1    Haagsma, C.J.2    van Riel, P.L.3
  • 8
    • 13444254086 scopus 로고    scopus 로고
    • Interleukin-18: A therapeutic target in rheumatoid arthritis?
    • McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther 2005;7:38-41.
    • (2005) Arthritis Res Ther , vol.7 , pp. 38-41
    • McInnes, I.B.1    Liew, F.Y.2    Gracie, J.A.3
  • 10
    • 0030070401 scopus 로고    scopus 로고
    • Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis
    • Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55:34-9.
    • (1996) Ann Rheum Dis , vol.55 , pp. 34-39
    • Eberhardt, K.1    Fex, E.2    Johnson, U.3    Wollheim, F.A.4
  • 13
    • 0001817366 scopus 로고
    • Cell biology of cartilage degradation
    • Henderson B, Edwards JC, Pettipher ER, editors, London: Academic Press;
    • Poole A, Alini M, Hollander A. Cell biology of cartilage degradation. In: Henderson B, Edwards JC, Pettipher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 163-204.
    • (1995) Mechanisms and models in rheumatoid arthritis , pp. 163-204
    • Poole, A.1    Alini, M.2    Hollander, A.3
  • 14
    • 0036822673 scopus 로고    scopus 로고
    • Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? [editorial]
    • Poole AR. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? [editorial]. Arthritis Rheum 2002;46:2549-52.
    • (2002) Arthritis Rheum , vol.46 , pp. 2549-2552
    • Poole, A.R.1
  • 15
    • 0028322114 scopus 로고
    • Biological markers in rheumatoid arthritis
    • Poole AR, Dieppe P. Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 1994;23 Suppl 2:17-31.
    • (1994) Semin Arthritis Rheum , vol.23 , Issue.SUPPL. 2 , pp. 17-31
    • Poole, A.R.1    Dieppe, P.2
  • 16
    • 0027588239 scopus 로고
    • Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis
    • Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K. Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1993;1:121-8.
    • (1993) Osteoarthritis Cartilage , vol.1 , pp. 121-128
    • Shinmei, M.1    Ito, K.2    Matsuyama, S.3    Yoshihara, Y.4    Matsuzawa, K.5
  • 17
    • 0028934327 scopus 로고
    • Cartilage and bone metabolism in rheumatoid arthritis: Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
    • Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, et al. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
    • (1995) J Clin Invest , vol.95 , pp. 1071-1077
    • Mansson, B.1    Carey, D.2    Alini, M.3    Ionescu, M.4    Rosenberg, L.C.5    Poole, A.R.6
  • 18
    • 70350491339 scopus 로고    scopus 로고
    • Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: An evaluation from 1 to 4 years after diagnosis
    • Verstappen S, Poole A, Ionescu M, King L, Abrahamowicz M, Hofman D, et al. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther 2006;8:R31.
    • (2006) Arthritis Res Ther , vol.8
    • Verstappen, S.1    Poole, A.2    Ionescu, M.3    King, L.4    Abrahamowicz, M.5    Hofman, D.6
  • 19
    • 2342499811 scopus 로고    scopus 로고
    • Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis
    • Landewe R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1390-9.
    • (2004) Arthritis Rheum , vol.50 , pp. 1390-1399
    • Landewe, R.1    Geusens, P.2    Boers, M.3    van der Heijde, D.4    Lems, W.5    te Koppele, J.6
  • 20
    • 0242579596 scopus 로고    scopus 로고
    • Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: Relationship to mediators of systemic and local inflammation
    • Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 2003;48:3085-95.
    • (2003) Arthritis Rheum , vol.48 , pp. 3085-3095
    • Fraser, A.1    Fearon, U.2    Billinghurst, R.C.3    Ionescu, M.4    Reece, R.5    Barwick, T.6
  • 21
    • 0024549792 scopus 로고
    • Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in expiants of bovine articular cartilage cultured with interleukin 1
    • Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in expiants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-61.
    • (1989) J Clin Invest , vol.83 , pp. 647-661
    • Dodge, G.R.1    Poole, A.R.2
  • 22
    • 0028328915 scopus 로고
    • Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay
    • Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
    • (1994) J Clin Invest , vol.93 , pp. 1722-1732
    • Hollander, A.P.1    Heathfield, T.F.2    Webber, C.3    Iwata, Y.4    Bourne, R.5    Rorabeck, C.6
  • 23
    • 0028839263 scopus 로고
    • Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration
    • Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
    • (1995) J Clin Invest , vol.96 , pp. 2859-2869
    • Hollander, A.P.1    Pidoux, I.2    Reiner, A.3    Rorabeck, C.4    Bourne, R.5    Poole, A.R.6
  • 24
  • 25
    • 0142029334 scopus 로고    scopus 로고
    • Mediators of inflammation, tissue destruction, and repair: D. Proteases and their inhibitors
    • Klippel JH, Crofford LJ, Stone JH, Weyand CM, editors, 12th ed. Atlanta: Arthritis Foundation;
    • Mort JS, Poole AR. Mediators of inflammation, tissue destruction, and repair: D. Proteases and their inhibitors. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM, editors. Primer on the rheumatic diseases. 12th ed. Atlanta: Arthritis Foundation; 2001. p. 72-81.
    • (2001) Primer on the rheumatic diseases , pp. 72-81
    • Mort, J.S.1    Poole, A.R.2
  • 26
    • 10344223475 scopus 로고    scopus 로고
    • The assessment of cartilage degradation in vivo: Development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases
    • Poole A, Ionescu M, Fitzcharles MA, Billinghurst RC. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 2004;294:145-53.
    • (2004) J Immunol Methods , vol.294 , pp. 145-153
    • Poole, A.1    Ionescu, M.2    Fitzcharles, M.A.3    Billinghurst, R.C.4
  • 27
    • 0035154449 scopus 로고    scopus 로고
    • Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis
    • Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44:120-7.
    • (2001) Arthritis Rheum , vol.44 , pp. 120-127
    • Kojima, T.1    Mwale, F.2    Yasuda, T.3    Girard, C.4    Poole, A.R.5    Laverty, S.6
  • 28
    • 0033575758 scopus 로고    scopus 로고
    • Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis
    • Song X, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, et al. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 1999;190:535-42.
    • (1999) J Exp Med , vol.190 , pp. 535-542
    • Song, X.1    Zeng, L.2    Jin, W.3    Thompson, J.4    Mizel, D.E.5    Lei, K.6
  • 29
    • 0028899665 scopus 로고
    • Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid
    • Shinmei M, Kobayashi T, Yoshihara Y, Samura A. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol Suppl 1995;43:78-81.
    • (1995) J Rheumatol Suppl , vol.43 , pp. 78-81
    • Shinmei, M.1    Kobayashi, T.2    Yoshihara, Y.3    Samura, A.4
  • 30
    • 10244234102 scopus 로고    scopus 로고
    • Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis
    • Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol 1996;23:1765-9.
    • (1996) J Rheumatol , vol.23 , pp. 1765-1769
    • Lohmander, L.S.1    Yoshihara, Y.2    Roos, H.3    Kobayashi, T.4    Yamada, H.5    Shinmei, M.6
  • 31
    • 0032535446 scopus 로고    scopus 로고
    • Evidence for altered synthesis of type II collagen in patients with osteoarthritis
    • Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998;102:2115-25.
    • (1998) J Clin Invest , vol.102 , pp. 2115-2125
    • Nelson, F.1    Dahlberg, L.2    Laverty, S.3    Reiner, A.4    Pidoux, I.5    Ionescu, M.6
  • 32
    • 1042301978 scopus 로고    scopus 로고
    • Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis
    • Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004;50:543-52.
    • (2004) Arthritis Rheum , vol.50 , pp. 543-552
    • Matyas, J.R.1    Atley, L.2    Ionescu, M.3    Eyre, D.R.4    Poole, A.R.5
  • 33
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3    McShane, D.J.4    Fries, J.F.5    Cooper, N.S.6
  • 34
    • 0027955027 scopus 로고
    • Classification of clinical subsets in psoriatic arthritis
    • Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
    • (1994) Br J Rheumatol , vol.33 , pp. 133-138
    • Veale, D.1    Rogers, S.2    FitzGerald, O.3
  • 35
    • 0028815803 scopus 로고
    • Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
    • Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
    • (1995) Arthritis Rheum , vol.38 , pp. 44-48
    • Prevoo, M.L.1    van 't Hof, M.A.2    Kuper, H.H.3    van Leeuwen, M.A.4    van de Putte, L.B.5    van Riel, P.L.6
  • 36
    • 33750331541 scopus 로고    scopus 로고
    • Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: Analysis of data from randomised, controlled trials of two tumour necrosis factor inhibitors
    • Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised, controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1373-1378
    • Fransen, J.1    Antoni, C.2    Mease, P.J.3    Uter, W.4    Kavanaugh, A.5    Kalden, J.R.6
  • 39
    • 13244272359 scopus 로고    scopus 로고
    • Deciding on progression of joint damage in paired films of individual patients: Smallest detectable difference or change
    • Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179-82.
    • (2005) Ann Rheum Dis , vol.64 , pp. 179-182
    • Bruynesteyn, K.1    Boers, M.2    Kostense, P.3    van der Linden, S.4    van der Heijde, D.5
  • 40
    • 33744744388 scopus 로고    scopus 로고
    • Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis
    • Mazzuca SA, Poole AR, Brandt KD, Katz BP, Lane KA, Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rheumatol 2006;33:1147-51.
    • (2006) J Rheumatol , vol.33 , pp. 1147-1151
    • Mazzuca, S.A.1    Poole, A.R.2    Brandt, K.D.3    Katz, B.P.4    Lane, K.A.5    Lobanok, T.6
  • 41
    • 26444474599 scopus 로고    scopus 로고
    • Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis
    • Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, et al. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol 2005;32:1911-7.
    • (2005) J Rheumatol , vol.32 , pp. 1911-1917
    • Maksymowych, W.P.1    Poole, A.R.2    Hiebert, L.3    Webb, A.4    Ionescu, M.5    Lobanok, T.6
  • 43
    • 0035306510 scopus 로고    scopus 로고
    • Uncoupling of inflammatory and destructive mechanisms in arthritis
    • Van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30(5 Suppl 2):7-16.
    • (2001) Semin Arthritis Rheum , vol.30 , Issue.5 SUPPL. 2 , pp. 7-16
    • Van den Berg, W.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.